CPT® Code 89337

1. Indications

The procedure of cryopreservation of mature oocytes is indicated for several specific conditions and circumstances that may affect a woman's reproductive health. These include:

• Risk of Primary Ovarian Insufficiency or Failure Women who are at risk for primary ovarian insufficiency or failure may benefit from this procedure to preserve their reproductive potential.
• Chemotherapy Treatment Women undergoing treatment with chemotherapeutic drugs, which can adversely affect ovarian function, are candidates for oocyte cryopreservation.
• Pelvic Radiotherapy Those receiving pelvic radiotherapy for cancer or other serious medical conditions may also be at risk for ovarian damage, making cryopreservation a viable option.
• Genetic/Chromosomal Abnormalities Women with certain genetic or chromosomal abnormalities, such as fragile X permutation and mosaicism for monosomy X, may require this procedure to safeguard their reproductive capabilities.

2. Procedure

The cryopreservation of mature oocytes involves several critical procedural steps that ensure the effective preservation of the oocytes. These steps include:

• Superovulation Initially, the patient undergoes a superovulation protocol, which involves the administration of hormonal medications to stimulate the ovaries to produce multiple mature oocytes. This step is essential to maximize the number of oocytes available for retrieval.
• Retrieval of Mature Oocytes Once the oocytes have matured, they are retrieved from the ovaries through a minor surgical procedure, typically performed under sedation. This process involves the use of a transvaginal ultrasound-guided needle to aspirate the oocytes from the ovarian follicles.
• Immersion in Cryopreservative After retrieval, the mature oocytes are immediately immersed in a highly concentrated cryopreservative solution. This solution may contain substances such as glycerol, propanediol, ethylene glycol, or dimethyl sulfate, which are crucial for protecting the oocytes during the freezing process.
• Vitrification The next step is vitrification, a rapid cooling technique that involves the use of liquid nitrogen. The oocytes are subjected to ultra-rapid cooling, which solidifies the cells and halts all biological activity, effectively preserving them for future use.

3. Post-Procedure

Following the cryopreservation procedure, patients may experience some mild discomfort or cramping, which is typically manageable. It is essential for patients to follow up with their healthcare provider to discuss the results of the oocyte retrieval and any further steps regarding their reproductive health. The cryopreserved oocytes can be stored for an extended period, allowing women to utilize them in future assisted reproductive technologies, such as in vitro fertilization (IVF), when they are ready to conceive. Proper storage conditions must be maintained to ensure the viability of the oocytes until they are needed.